University of British Columbia
Epidemiology, Substance misuse, HIV-HCV coinfection

M-J Milloy, PhD, an infectious disease epidemiologist, is an assistant professor in the Division of AIDS in the Department of Medicine at UBC, a research scientist with UHRI and the Principal Investigator of the Aids Care Cohort to Evaluate Access to Survival Services (ACCESS), an ongoing prospective cohort of approximately 1,000 individuals living with HIV/AIDS who use illicit drugs funded by the United States National Institutes of Health. His research focuses on the interrelationships between illicit drugs and HIV/AIDS, such as HIV/AIDS treatment patterns among people who use illicit drugs and the effect of cannabis on HIV/AIDS drug progression.

During his more than nine years with UHRI, he has authored more than 80 articles in the scientific literature on topics including: the impacts of homelessness and incarceration on HIV treatment outcomes; patterns of nonfatal and fatal overdose; and the effects of Insite, Vancouver'ssupervised injection facility. Dr. Milloy has won several awards of merit, including the 2011 Bisby Fellowship from the Canadian Institutes of Health Research. His research recently attracted a $1-million gift to UBC from NG Biomed, a medical cannabis firm.